207 related articles for article (PubMed ID: 10194064)
41. Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids.
von Schlieffen E; Oskolkova OV; Schabbauer G; Gruber F; Blüml S; Genest M; Kadl A; Marsik C; Knapp S; Chow J; Leitinger N; Binder BR; Bochkov VN
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):356-62. PubMed ID: 19112167
[TBL] [Abstract][Full Text] [Related]
42. Non-LPS targets and actions of LPS binding protein (LBP).
Schröder NW; Schumann RR
J Endotoxin Res; 2005; 11(4):237-42. PubMed ID: 16176661
[TBL] [Abstract][Full Text] [Related]
43. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation.
Su GL
Am J Physiol Gastrointest Liver Physiol; 2002 Aug; 283(2):G256-65. PubMed ID: 12121871
[TBL] [Abstract][Full Text] [Related]
44. Interaction between CD14 lipopolysaccharide binding protein and bactericidal/permeability-increasing protein during lipopolysaccharide-induced cell activation.
Dentener MA; Von Asmuth EJ; Francot GJ; Buurman WA
Prog Clin Biol Res; 1994; 388():59-70. PubMed ID: 7530372
[No Abstract] [Full Text] [Related]
45. Treponemal glycoconjugate inhibits Toll-like receptor ligand-induced cell activation by blocking LPS-binding protein and CD14 functions.
Asai Y; Hashimoto M; Ogawa T
Eur J Immunol; 2003 Nov; 33(11):3196-204. PubMed ID: 14579288
[TBL] [Abstract][Full Text] [Related]
46. Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4.
Su GL; Klein RD; Aminlari A; Zhang HY; Steinstraesser L; Alarcon WH; Remick DG; Wang SC
Hepatology; 2000 Apr; 31(4):932-6. PubMed ID: 10733550
[TBL] [Abstract][Full Text] [Related]
47. LPS induces CD14 association with complement receptor type 3, which is reversed by neutrophil adhesion.
Zarewych DM; Kindzelskii AL; Todd RF; Petty HR
J Immunol; 1996 Jan; 156(2):430-3. PubMed ID: 8543790
[TBL] [Abstract][Full Text] [Related]
48. Identification by surface plasmon resonance of the mycobacterial lipomannan and lipoarabinomannan domains involved in binding to CD14 and LPS-binding protein.
Elass E; Coddeville B; Guérardel Y; Kremer L; Maes E; Mazurier J; Legrand D
FEBS Lett; 2007 Apr; 581(7):1383-90. PubMed ID: 17350002
[TBL] [Abstract][Full Text] [Related]
49. Lipopolysaccharide binding protein and serum amyloid A secretion by human intestinal epithelial cells during the acute phase response.
Vreugdenhil AC; Dentener MA; Snoek AM; Greve JW; Buurman WA
J Immunol; 1999 Sep; 163(5):2792-8. PubMed ID: 10453023
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction.
Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O
J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844
[TBL] [Abstract][Full Text] [Related]
51. CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria.
Heumann D
J Endotoxin Res; 2001; 7(6):439-41. PubMed ID: 11753213
[TBL] [Abstract][Full Text] [Related]
52. [Endotoxin and its binding protein in organ failure].
Usui M; Kawarada Y
Nihon Geka Gakkai Zasshi; 1998 Aug; 99(8):504-9. PubMed ID: 9789285
[TBL] [Abstract][Full Text] [Related]
53. Endotoxin-induced expression of endotoxin binding sites on murine bone marrow cells.
Girard R; Pedron T; Chaby R
J Immunol; 1993 May; 150(10):4504-13. PubMed ID: 7683322
[TBL] [Abstract][Full Text] [Related]
54. Interaction of endotoxins with Toll-like receptor 4 correlates with their endotoxic potential and may explain the proinflammatory effect of Brucella spp. LPS.
Dueñas AI; Orduña A; Crespo MS; García-Rodríguez C
Int Immunol; 2004 Oct; 16(10):1467-75. PubMed ID: 15339879
[TBL] [Abstract][Full Text] [Related]
55. Inactivation of endotoxin by human plasma gelsolin.
Bucki R; Georges PC; Espinassous Q; Funaki M; Pastore JJ; Chaby R; Janmey PA
Biochemistry; 2005 Jul; 44(28):9590-7. PubMed ID: 16008344
[TBL] [Abstract][Full Text] [Related]
56. CD14 and lipopolysaccharide binding protein expression in a rat model of alcoholic liver disease.
Su GL; Rahemtulla A; Thomas P; Klein RD; Wang SC; Nanji AA
Am J Pathol; 1998 Mar; 152(3):841-9. PubMed ID: 9502426
[TBL] [Abstract][Full Text] [Related]
57. Mechanisms of transcriptional activation of lipopolysaccharide binding protein (LBP).
Schumann RR
Prog Clin Biol Res; 1995; 392():297-304. PubMed ID: 8524934
[TBL] [Abstract][Full Text] [Related]
58. Lipopolysaccharide binding protein from normal human plasma purified with high efficiency.
Nanbo A; Nishimura H; Nagasawa S
Protein Expr Purif; 1997 Jun; 10(1):55-60. PubMed ID: 9179291
[TBL] [Abstract][Full Text] [Related]
59. Control of transcriptional activation of the lipopolysaccharide binding protein (LBP) gene by proinflammatory cytokines.
Kirschning C; Unbehaun A; Lamping N; Pfeil D; Herrmann F; Schumann RR
Cytokines Cell Mol Ther; 1997 Mar; 3(1):59-62. PubMed ID: 9287245
[TBL] [Abstract][Full Text] [Related]
60. Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations.
Lei MG; Morrison DC
J Immunol; 1988 Aug; 141(3):996-1005. PubMed ID: 2456339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
